"10.1371_journal.pone.0145977","plos one","2016-01-11T00:00:00Z","Girishanthy Krishnarajah; Mei Sheng Duh; Caroline Korves; Kitaw Demissie","GlaxoSmithKline Vaccines, King of Prussia, Pennsylvania, United States of America; Analysis Group, Inc., Boston, Massachusetts, United States of America; Rutgers University, School of Public Health, Piscataway, New Jersey, United States of America; Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States of America","Conceived and designed the experiments: GK MSD CK KD. Analyzed the data: GK MSD CK KD. Wrote the paper: GK MSD CK KD.","GlaxoSmithKline Biologicals SA funded this study/research and was involved in all stages of study conduct, including analysis of the data. GlaxoSmithKline Biologicals SA also took in charge all costs associated with the development and publication of this manuscript. Girishanthy Krishnarajah is an employee of and has restricted shares in the GlaxoSmithKline group of companies. Mei Sheng Duh and Caroline Korves are employees of Analysis Group which received funding from GSK to conduct this research and receives funding to conduct other drug safety and health outcomes research from multiple pharmaceutical companies. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2016","01","Girishanthy Krishnarajah","GK",4,TRUE,4,NA,4,4,TRUE,TRUE,FALSE,0,NA,FALSE
